To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Cost and committee reports

Official records Congress.gov attaches to H.R. 383.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mrs. HARSHBARGER, as printed in the Congressional Record (Vol. 169, No. 12, January 17, 2023, Page H244):
  Article I, Section 8 of the United States Constitution
  Source: Congress.gov, Congressional Record January 17, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  54 characters

  Congress.gov bill record

  H.R. 383, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/383

  Record last updated by Congress.gov

  June 12, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  21900b7c4cdd97be1a36407059d4438da5ef319a382c079a372f7a65664dbaf3

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of June 12, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 383, last updated June 12, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.